Nucleoside-derived antagonists to A3adenosine receptors lower mouse intraocular pressure and act across species

Zhao Wang, Chi Wai Do, Marcel Y. Avila, Kim Peterson-Yantorno, Richard A. Stone, Zhan Guo Gao, Bhalchandra Joshi, Pedro Besada, Lak Shin Jeong, Kenneth A. Jacobson, Mortimer M. Civan

Research output: Journal article publicationJournal articleAcademic researchpeer-review

33 Citations (Scopus)

Abstract

The purpose of the study was to determine whether novel, selective antagonists of human A3adenosine receptors (ARs) derived from the A3-selective agonist Cl-IB-MECA lower intraocular pressure (IOP) and act across species. IOP was measured invasively with a micropipette by the Servo-Null Micropipette System (SNMS) and by non-invasive pneumotonometry during topical drug application. Antagonist efficacy was also assayed by measuring inhibition of adenosine-triggered shrinkage of native bovine nonpigmented ciliary epithelial (NPE) cells. Five agonist-based A3AR antagonists lowered mouse IOP measured with SNMS tonometry by 3-5 mm Hg within minutes of topical application. Of the five agonist derivatives, LJ 1251 was the only antagonist to lower IOP measured by pneumotonometry. No effect was detected pneumotonometrically over 30 min following application of the other four compounds, consonant with slower, smaller responses previously measured non-invasively following topical application of A3AR agonists and the dihydropyridine A3AR antagonist MRS 1191. Latanoprost similarly lowered SNMS-measured IOP, but not IOP measured non-invasively over 30 min. Like MRS 1191, agonist-based A3AR antagonists applied to native bovine NPE cells inhibited adenosine-triggered shrinkage. In summary, the results indicate that antagonists of human A3ARs derived from the potent, selective A3agonist Cl-IB-MECA display efficacy in mouse and bovine cells, as well. When intraocular delivery was enhanced by measuring mouse IOP invasively, five derivatives of the A3AR agonist Cl-IB-MECA lowered IOP but only one rapidly reduced IOP measured non-invasively after topical application. We conclude that derivatives of the highly-selective A3AR agonist Cl-IB-MECA can reduce IOP upon reaching their intraocular target, and that nucleoside-based derivatives are promising A3antagonists for study in multiple animal models.
Original languageEnglish
Pages (from-to)146-154
Number of pages9
JournalExperimental Eye Research
Volume90
Issue number1
DOIs
Publication statusPublished - 1 Jan 2010

Keywords

  • aqueous humor
  • bovine nonpigmented ciliary epithelial cells
  • nucleoside-based antagonists
  • pneumotonometry
  • servo-null micropipette system

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience

Cite this